Mesoblast Limited (MESO)
Nasdaq: MESO · Biological Products, (No Diagnostic Substances) · Melbourne, Victoria, AU · filing with the SEC since 2005
Who owns Mesoblast Limited
As filed with the SECHolders of 5% or more
2
George, Gregory holds 22.4% of Ordinary Shares / American Depositary Receipts, as its SCHEDULE 13G/A filed Mar 11, 2026 says.
Directors and officers
9
report now, of 9 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
George, Gregory
SCHEDULE 13G/A · filed Mar 11, 2026 · Ordinary Shares / American Depositary Receipts · 21.6% in Sep 12, 2025
Gueck William J.
SCHEDULE 13G · filed Sep 16, 2025 · Ordinary Shares
What MESO reports owning in othersstakes of 5% or more, and other ties
4 subsidiaries in 3 countries, from the list filed with the 20-F filed Aug 31, 2023.
Insider tradesForm 4
0sales
30purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$37.5Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 9 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| George Gregory | director | 0 | $0 | 0 | 30 | $37.5M |